Voyager Therapeutics (VYGR) Cash & Equivalents (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Voyager Therapeutics | 230.25 Mn | 88.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.67% |
| Dec 31, 2025 | 44.71% |
| Sep 30, 2025 | 2.70% |
| Jun 30, 2025 | -41.22% |
| Mar 31, 2025 | 4.75% |
| Dec 31, 2024 | -36.58% |
| Sep 30, 2024 | 47.81% |
| Jun 30, 2024 | -46.79% |
| Mar 31, 2024 | 107.96% |
| Dec 31, 2023 | 5.41% |
| Sep 30, 2023 | -73.28% |
| Jun 30, 2023 | -8.95% |
| Mar 31, 2023 | 171.14% |
| Dec 31, 2022 | 2.17% |
| Sep 30, 2022 | 23.66% |
| Jun 30, 2022 | -40.60% |
| Mar 31, 2022 | 12.30% |
| Dec 31, 2021 | 5.34% |
| Sep 30, 2021 | -5.40% |
| Jun 30, 2021 | 0.04% |
| Mar 31, 2021 | 12.79% |
| Dec 31, 2020 | -29.17% |
| Sep 30, 2020 | 2.17% |
| Jun 30, 2020 | -12.65% |
| Mar 31, 2020 | 92.03% |
| Dec 31, 2019 | 4.12% |
| Sep 30, 2019 | 3.45% |
| Jun 30, 2019 | -29.47% |
| Mar 31, 2019 | 141.71% |
| Dec 31, 2018 | 11.19% |
| Sep 30, 2018 | -29.31% |
| Jun 30, 2018 | -57.53% |
| Mar 31, 2018 | 345.20% |
| Dec 31, 2017 | -34.59% |
| Sep 30, 2017 | -27.30% |
| Jun 30, 2017 | 52.05% |
| Mar 31, 2017 | 19.00% |
| Dec 31, 2016 | -42.30% |
| Sep 30, 2016 | -5.26% |
| Jun 30, 2016 | 97.76% |
| Mar 31, 2016 | 8.26% |
| Dec 31, 2015 | -52.94% |
| Sep 30, 2015 | -21.49% |
| Jun 30, 2015 | -27.20% |
| Mar 31, 2015 | 1,554.78% |
| Dec 31, 2014 | 11.14% |